Sepsis Versus Infection: What the Sepsis-3 Definition Changed

Sepsis-3, the 2016 international consensus published in JAMA by Singer and colleagues, redefined sepsis as "life-threatening organ dysfunction caused by a dysregulated host response to infection." That single sentence moved the concept away from inflammation and toward the failure of organs, and it attached a measurable threshold: an acute rise of 2 or more points on the Sequential Organ Failure Assessment (SOFA) score in a patient with suspected infection. The older systemic inflammatory response syndrome (SIRS) criteria were dropped from the definition. A bedside prompt called qSOFA was introduced at the same time, and, as I will explain, it was never meant to define sepsis at all.

From inflammation to organ dysfunction

Before 2016, sepsis was framed largely as infection plus a systemic inflammatory response. The Sepsis-3 task force argued that inflammation is a normal and often protective part of fighting infection, so a definition built on inflammatory signs told you little about who was actually in danger. The reframing puts the dangerous element front and center: it is the host response going wrong and injuring the body's own organs, not the microbe alone, that makes sepsis lethal.

Operationally, the consensus tied this to the SOFA score, which grades dysfunction across six systems (respiration, coagulation, liver, cardiovascular, central nervous system, and kidney). A rise of at least 2 points, assuming a baseline of zero in patients not known to have prior organ dysfunction, marks the organ dysfunction that defines sepsis. Singer and colleagues reported that this threshold is associated with in-hospital mortality above 10 percent among patients with suspected infection, a risk higher than that of many conditions the public regards as serious. Septic shock was defined more narrowly, as a subset in which circulatory and metabolic derangements are severe enough to require vasopressors to keep mean arterial pressure at 65 mm Hg or above, together with a serum lactate greater than 2 mmol/L despite adequate fluid resuscitation. That combination was linked to hospital mortality above 40 percent.

Why SIRS was retired

The systemic inflammatory response syndrome criteria (abnormal temperature, heart rate, respiratory rate, and white cell count) had anchored the definition since the early 1990s. The task force retired them from the definition for two reasons it stated plainly. First, they lacked specificity: a large share of hospitalized patients meet two SIRS criteria at some point without ever being septic or coming to harm, so the label swept in many people who were not in danger. Second, they could miss real disease: the accompanying analysis noted that some patients who developed infection-related organ failure and died never met two SIRS criteria, so a rule that required them would have overlooked genuine cases. A tool that is both over-inclusive and capable of missing lethal illness is a weak foundation for a definition, which is why SIRS was moved out of the definitional role.

qSOFA: what it is, and what it is not

Alongside the definition, the derivation study by Seymour and colleagues, published in the same 2016 issue of JAMA, introduced quick SOFA, or qSOFA. It uses three bedside findings and no laboratory tests: respiratory rate of 22 breaths per minute or higher, altered mental status, and systolic blood pressure of 100 mm Hg or lower. Two or more of these in a patient with suspected infection identified a group with markedly worse outcomes.

Here the wording matters. qSOFA was proposed as a prompt, a way to raise suspicion and encourage clinicians to look harder for organ dysfunction, increase monitoring, or consider critical care. It was explicitly not offered as a definition of sepsis, not a stand-alone diagnostic test, and not a replacement for the SOFA-based criteria. That distinction has been reinforced since. The 2021 Surviving Sepsis Campaign guidelines issued a strong recommendation against using qSOFA as a single screening tool, precisely because it is specific but not sensitive. In the original data, only about a quarter of infected patients had a positive qSOFA, yet that group accounted for the large majority of poor outcomes. A positive qSOFA should raise concern; a negative one does not rule sepsis out. Treating it as a rule-out test misreads what it was built to do.

Why the distinction carries weight

Definitions are not academic housekeeping. They shape who gets counted in surveillance, who is enrolled in clinical trials, and how quickly a deteriorating patient is recognized. By anchoring sepsis to organ dysfunction rather than inflammation, Sepsis-3 aimed to make the label track the danger more faithfully. The framework has also drawn fair criticism worth acknowledging: SOFA was designed to describe intensive care populations rather than to diagnose at the front door, and applying these criteria in lower-resource settings or in children requires care and separate validation. Reading Sepsis-3 well means holding both ideas at once. It sharpened the concept, and it left open questions that later guidelines and pediatric definitions continue to work on.

The practical takeaway for a general reader is modest and worth stating clearly. Sepsis is the body's own response to infection turning against its organs, it is a time-sensitive emergency, and the presence or absence of any single bedside score does not settle the question. This article is educational and not medical advice; anyone worried about an infection accompanied by confusion, fast breathing, or a drop in blood pressure should seek urgent clinical care.